Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline.

Discover top biotech associations that drive industry growth through collaboration, networking, and strategic partnerships ...

Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease.

RNA editing has picked up steam in recent years as a potentially safer alternative to gene editing to treat genetic diseases.

On a mission to overcome the dosing challenges posed by radiotherapy, French nanotherapy company Nanobiotix is developing a ...

As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related ...

Discover advances in epilepsy treatments, innovative solutions for seizure freedom, and challenges in integrating new ...

Discover Booster Therapeutics' novel 20S proteasome activation approach to neurodegenerative diseases as it launches with $15 ...

Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...

JAK inhibitors have gained particular attention in the inflammation and immunology (I&I) space, an area that has brought in a wave of investment in recent times. Pharma giants such as Pfizer and ...